UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 14, 2017 4:30 P.M.

Form:	S-3
CIK: 0001109196 Company Name: MABVAX THERAPEUTICS HOLDINGS, INC. File Number: 333-218473